ウイルス不活性化の市場規模、シェア、成長分析：方法別、製品別、用途別、エンドユーザー別、地域別 - 産業予測 2025～2032年

ウイルス不活性化の世界市場規模は、2023年に6億237万米ドルと評価され、2024年の6億7,646万米ドルから2032年には17億1,112万米ドルに成長し、予測期間（2025～2032年）のCAGRは12.3％で成長する見通しです。

世界のウイルス不活性化市場は、医薬品、バイオテクノロジー、ヘルスケアにおける効果的なウイルスクリアランスに対する需要の高まりに牽引され、大幅な拡大が見込まれています。バイオ医薬品の生産が増加しているため、生物学的製剤、ワクチン、治療薬から感染因子を排除するための厳格なウイルス安全対策が必要とされています。FDAやEMAのような組織からの規制遵守は極めて重要であり、企業は汚染リスクを低減するための強固な技術へと向かっています。バイオマニュファクチャリングにおけるシングルユース技術の採用が進むにつれ、安全性と効率性が向上する一方、これらの分野におけるアウトソーシングの増加が、調査業務を専門とする受託機関の需要を押し上げています。継続的な技術の進歩と安全性の重視により、市場は革新的なソリューションと戦略的パートナーシップのための十分な機会を提供し、公衆衛生上の懸念の中で持続的な成長を確実なものにしています。

目次

イントロダクション

• 調査の目的
• 調査範囲
• 定義

調査手法

• 情報調達
• 二次データと一次データの方法
• 市場規模予測
• 市場の前提条件と制限

エグゼクティブサマリー

• 世界市場の見通し
• 供給と需要の動向分析
• セグメント別機会分析

市場力学と見通し

• 市場概要
• 市場規模
• 市場力学
  • 促進要因と機会
  • 抑制要因と課題
• ポーターの分析

主な市場の考察

• 重要成功要因
• 競合の程度
• 主な投資機会
• 市場エコシステム
• 市場の魅力指数（2024年）
• PESTEL分析
• マクロ経済指標
• バリューチェーン分析
• 価格分析

ウイルス不活性化市場規模：方法別

• 市場概要
• 溶剤洗剤法
• 殺菌法
• その他のウイルス不活性化法

ウイルス不活性化市場規模：製品別

• 市場概要
• キットと試薬
• サービス
• ウイルス不活性化システムと付属品

ウイルス不活性化市場規模：用途別

• 市場概要
• 血液および血液製品
• 細胞・遺伝子治療製品
• 幹細胞製品
• ティッシュおよびティッシュ製品
• ワクチンと治療薬

ウイルス不活性化市場規模：エンドユーザー別

• 市場概要
• 製薬・バイオテクノロジー企業
• 契約調査機関
• 学術調査機関
• その他のエンドユーザー

ウイルス不活性化市場規模

• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他欧州地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

競合情報

• 上位5社の比較
• 主要企業の市場ポジショニング（2024年）
• 主な市場企業が採用した戦略
• 市場の最近の動向
• 企業の市場シェア分析（2024年）
• 主要企業の企業プロファイル
  • 会社概要
  • 製品ポートフォリオ分析
  • セグメント別シェア分析
  • 収益の前年比比較（2022～2024年）

主要企業プロファイル

• Merck KGaA（Germany）
• Sartorius AG（Germany）
• Charles River Laboratories International, Inc.（United States）
• Parker Hannifin Corporation（United States）
• Thermo Fisher Scientific Inc.（United States）
• Bio-Rad Laboratories, Inc.（United States）
• Mettler-Toledo International Inc.（United States）
• SGS SA（Switzerland）
• WuXi AppTec Co., Ltd.（China）
• Lonza Group AG（Switzerland）
• Pfizer Inc.（United States）
• GE HealthCare Technologies Inc.（United States）
• Danaher Corporation（United States）
• Cerus Corporation（United States）
• Terumo BCT, Inc.（United States）
• Eurofins Scientific SE（Luxembourg）
• Macopharma SA（France）
• Kedrion S.p.A.（Italy）
• Rad Source Technologies, Inc.（United States）

結論と推奨事項

Global Viral Inactivation Market size was valued at USD 602.37 million in 2023 and is poised to grow from USD 676.46 million in 2024 to USD 1711.12 million by 2032, growing at a CAGR of 12.3% during the forecast period (2025-2032).

The global viral inactivation market is set for significant expansion, driven by a rising demand for effective viral clearance in pharmaceuticals, biotechnology, and healthcare. The increasing production of biopharmaceuticals necessitates stringent viral safety measures to eliminate infectious agents from biological products, vaccines, and therapeutics. Regulatory compliance from organizations like the FDA and EMA is crucial, pushing companies toward robust techniques to reduce contamination risks. The growing adoption of single-use technologies in biomanufacturing enhances safety and efficiency, while the rise in outsourcing within these sectors boosts demand for contract research organizations specializing in viral inactivation services. With ongoing technological advancements and a focus on safety, the market offers ample opportunities for innovative solutions and strategic partnerships, ensuring sustained growth amid public health concerns.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Viral Inactivation market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Viral Inactivation Market Segmental Analysis

Global Viral Inactivation Market is segmented by Method, Product, Application, End User and region. Based on Method, the market is segmented into Solvent Detergent Method, Pasteurization and Other Viral Inactivation Method. Based on Product, the market is segmented into Kits and Reagents, Services and Viral Inactivation Systems and Accessories. Based on Application, the market is segmented into Blood & Blood Products, Cellular & Gene Therapy Products, Stem Cell Products, Tissue & Tissue Products and Vaccines and Therapeutics. Based on End User, the market is segmented into Pharmaceutical and Biotechnology Companies, Contract Research Organizations, Academic Research Institutes and Other End Users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Viral Inactivation Market

The Global Viral Inactivation market is significantly influenced by advancements in the biopharmaceutical sector, particularly in the development of monoclonal antibodies, gene therapies, and personalized medicine. As the production of intricate biologics and innovative therapies expands, the necessity for reliable viral inactivation techniques intensifies in order to safeguard the integrity and safety of these treatments. This growing demand is further fueled by stringent regulatory requirements and a heightened focus on delivering high-quality, contaminant-free biopharmaceutical products. Consequently, the pursuit of effective viral inactivation solutions is essential to address these challenges and ensure the safe development of cutting-edge medical advancements.

Restraints in the Global Viral Inactivation Market

The viral inactivation market faces significant restraints due to the complex regulatory environment that governs the pharmaceutical and biotechnology industries. The stringent and constantly changing requirements established by regulatory bodies like the FDA and EMA complicate the navigation for businesses in this field. Companies are often required to conduct extensive validation studies and maintain rigorous documentation to prove the efficacy of their viral inactivation techniques, which can be both time-intensive and costly. This intricate regulatory landscape can hinder market growth and innovation by placing additional burdens on companies as they strive to meet compliance standards.

Market Trends of the Global Viral Inactivation Market

The Global Viral Inactivation market is experiencing a robust upward trend, propelled by the surge in biopharmaceutical manufacturing, particularly with the rise of monoclonal antibodies, gene therapies, and cell-based therapies. As these innovative biologics become essential for tailored therapeutic approaches, there is an increasing imperative for enhanced viral safety protocols to mitigate contamination risks. This demand is catalyzing the adoption of advanced viral inactivation techniques, reflecting a broader industry transition towards cutting-edge treatment modalities and the integration of sophisticated technologies. Consequently, this trend is significantly contributing to the market's expansion, signaling a pivotal evolution in biopharmaceutical safety standards and practices.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Viral Inactivation Market Size by Method & CAGR (2025-2032)

• Market Overview
• Solvent Detergent Method
• Pasteurization
• Other Viral Inactivation Method

Global Viral Inactivation Market Size by Product & CAGR (2025-2032)

• Market Overview
• Kits and Reagents
• Services
• Viral Inactivation Systems and Accessories

Global Viral Inactivation Market Size by Application & CAGR (2025-2032)

• Market Overview
• Blood & Blood Products
• Cellular & Gene Therapy Products
• Stem Cell Products
• Tissue & Tissue Products
• Vaccines and Therapeutics

Global Viral Inactivation Market Size by End User & CAGR (2025-2032)

• Market Overview
• Pharmaceutical and Biotechnology Companies
• Contract Research Organizations
• Academic Research Institutes
• Other End Users

Global Viral Inactivation Market Size & CAGR (2025-2032)

• North America (Method, Product, Application, End User)
  • US
  • Canada
• Europe (Method, Product, Application, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Method, Product, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Method, Product, Application, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Method, Product, Application, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Merck KGaA (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sartorius AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Charles River Laboratories International, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Parker Hannifin Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mettler-Toledo International Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SGS SA (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• WuXi AppTec Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lonza Group AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pfizer Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GE HealthCare Technologies Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cerus Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Terumo BCT, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eurofins Scientific SE (Luxembourg)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Macopharma SA (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Kedrion S.p.A. (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Rad Source Technologies, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations